Emerging carrier‐free nanosystems based on molecular self‐assembly of pure drugs for cancer therapy
Author:
Affiliation:
1. Department of PharmaceuticsWuya College of Innovation, Shenyang Pharmaceutical University Shenyang Liaoning China
2. Department of PharmacyCancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute Shenyang Liaoning China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21669
Reference107 articles.
1. Cancer statistics, 2018
2. World Health Organization.Cancer prevention. Accessed October 9 2019.https://www.who.int/cancer/prevention/en/
3. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
4. Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics
5. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. AIEgen-functionalized nanoprobes and nanomedicines for cancer diagnosis and therapy;Coordination Chemistry Reviews;2024-12
2. Advancements of engineered live oncolytic biotherapeutics (microbe/virus/cells): Preclinical research and clinical progress;Journal of Controlled Release;2024-11
3. Cholesterol sulfate-mediated ion-pairing facilitates the self-nanoassembly of hydrophilic cationic mitoxantrone;Journal of Colloid and Interface Science;2024-09
4. Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy;ACS Applied Materials & Interfaces;2024-08-27
5. Carrier-free nanoparticles based on self-assembly of 5-FU and copper-genistein complexes for the combined treatment of hepatocellular carcinoma;Drug Delivery and Translational Research;2024-08-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3